N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide

C39H51N7O7 — CID 70339946

IUPACN-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide
SMILESCCCC(NC(=O)[C@@H]1C[C@@H](Oc2ccccc2)CN1C(=O)[C@@H](NC(=O)C(NC(=O)c1cnccn1)=C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1
InChIInChI=1S/C39H51N7O7/c1-5-12-28(32(47)37(51)42-25-17-18-25)43-35(49)30-21-27(53-26-15-10-7-11-16-26)23-46(30)38(52)33(39(2,3)4)45-36(50)31(24-13-8-6-9-14-24)44-34(48)29-22-40-19-20-41-29/h7,10-11,15-16,19-20,22,25,27-28,30,33H,5-6,8-9,12-14,17-18,21,23H2,1-4H3,(H,42,51)(H,43,49)(H,44,48)(H,45,50)/t27-,28?,30+,33-/m1/s1
InChIKeyWWZVBVNEBCEGPE-ULDNBZHMSA-N
MW729.88 g/mol
LogP3.14
Rot. Bonds14

About N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide

N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide (PubChem CID 70339946) has the molecular formula C39H51N7O7 and a molecular weight of 729.88 g/mol. Its IUPAC name is N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide.

Molecular Properties

Compound NameN-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide
PubChem CID70339946
Molecular FormulaC39H51N7O7
Molecular Weight729.88 g/mol
Exact Mass729.38
IUPAC NameN-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide
SMILESCCCC(NC(=O)[C@@H]1C[C@@H](Oc2ccccc2)CN1C(=O)[C@@H](NC(=O)C(NC(=O)c1cnccn1)=C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1
InChIInChI=1S/C39H51N7O7/c1-5-12-28(32(47)37(51)42-25-17-18-25)43-35(49)30-21-27(53-26-15-10-7-11-16-26)23-46(30)38(52)33(39(2,3)4)45-36(50)31(24-13-8-6-9-14-24)44-34(48)29-22-40-19-20-41-29/h7,10-11,15-16,19-20,22,25,27-28,30,33H,5-6,8-9,12-14,17-18,21,23H2,1-4H3,(H,42,51)(H,43,49)(H,44,48)(H,45,50)/t27-,28?,30+,33-/m1/s1
InChIKeyWWZVBVNEBCEGPE-ULDNBZHMSA-N
XLogP3.14
TPSA188.79 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds14
Heavy Atoms53
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500729.88
LogP ≤ 53.14
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide?
The IUPAC name of N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide (CID 70339946) is N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide.
What is the SMILES notation for N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide?
The canonical SMILES for N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide is CCCC(NC(=O)[C@@H]1C[C@@H](Oc2ccccc2)CN1C(=O)[C@@H](NC(=O)C(NC(=O)c1cnccn1)=C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1.
What is the InChIKey of N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide?
The InChIKey is WWZVBVNEBCEGPE-ULDNBZHMSA-N. The full InChI is InChI=1S/C39H51N7O7/c1-5-12-28(32(47)37(51)42-25-17-18-25)43-35(49)30-21-27(53-26-15-10-7-11-16-26)23-46(30)38(52)33(39(2,3)4)45-36(50)31(24-13-8-6-9-14-24)44-34(48)29-22-40-19-20-41-29/h7,10-11,15-16,19-20,22,25,27-28,30,33H,5-6,8-9,12-14,17-18,21,23H2,1-4H3,(H,42,51)(H,43,49)(H,44,48)(H,45,50)/t27-,28?,30+,33-/m1/s1.
What are the key properties of N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide?
N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide has a molecular weight of 729.88 g/mol, XLogP of 3.14, 14 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-cyclohexylidene-2-[[(2S)-1-[(2S,4R)-2-[[1-(cyclopropylamino)-1,2-dioxohexan-3-yl]carbamoyl]-4-phenoxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide is sourced from PubChem (CID 70339946), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).